Cargando…
TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer
The biggest challenge for the treatment of multidrug resistant cancer is to deliver a high concentration of anticancer drugs to cancer cells. Icariside II is a flavonoid from Epimedium koreanum Nakai with remarkable anticancer properties, but poor solubility and significant efflux from cancer cells...
Autores principales: | Song, Jie, Huang, Houcai, Xia, Zhi, Wei, Yingjie, Yao, Nan, Zhang, Li, Yan, Hongmei, Jia, Xiaobin, Zhang, Zhenhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739176/ https://www.ncbi.nlm.nih.gov/pubmed/26293804 http://dx.doi.org/10.1177/1534735415596571 |
Ejemplares similares
-
Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer
por: Saxena, Vipin, et al.
Publicado: (2012) -
Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS
Mixed Micelles
por: Wang, Yingzhe, et al.
Publicado: (2014) -
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
por: Tang, Lan, et al.
Publicado: (2021) -
Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance
por: Dong, Kai, et al.
Publicado: (2016) -
Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer
por: Yang, Lei, et al.
Publicado: (2017)